UPDATE : Tuesday, September 17, 2019
상단여백
Kolmar apologizes for playing controversial YouTube clip
Kolmar Korea, the nation’s largest manufacturer of cosmetic products which ...
by Lee Han-soo  |  2019-08-09 16:48
라인
Diabetes drug Jardiance pressures heart failure treatment Entresto
Novartis’ new heart failure treatment Entresto (ingredient: sacubitril/vals...
by Kim Yun-mi  |  2019-08-09 15:44
라인
Only 1% of severe epilepsy patients get surgery in Korea
Most Korean patients with severe epilepsy -- except for 1.3 percent of them...
by Song Soo-youn  |  2019-08-09 13:48
라인
AstraZeneca’s Lynparza show positive results for prostate cancer in P3 trial
AstraZeneca and MSD announced positive results from their phase 3 PROfound ...
by Lee Han-soo  |  2019-08-08 16:48
라인
Mammotome procedure recognized as new medical technology
The health authorities have finally acknowledged ultrasound-guided vacuum-a...
by Choi Gwang-seok  |  2019-08-08 16:02
라인
SNUH resumes operation of UAE hospital
Seoul National University Hospital (SNUH) said that it launched the second-...
by Lee Han-soo  |  2019-08-08 15:59
라인
Drug regulator to enhance clinical trial management by 2023
The Ministry of Food and Drug Safety on Thursday announced a “Comprehensive...
by Lee Hye-seon  |  2019-08-08 14:55
라인
Preoperative embolization proves effective against non-hypervascular metastatic spine tumors
Researchers at St.Mary’s Seoul Hospital have concluded preoperative emboliz...
by Lee Han-soo  |  2019-08-08 14:54
라인
‘CPhI Korea thriving on local firms’ zeal for drug export’
Korea Pharmaceutical Traders Association (KPTA) said it would open a large-...
by Jeong Sae-im  |  2019-08-08 14:54
라인
Hanmi’s US partner unveils P3 data on oral anticancer drug
Athenex, Hanmi’s U.S. partner, presented the topline data showing that Orax...
by Lee Han-soo  |  2019-08-08 14:53
라인
'Daewoong risk' could put a damper on AbbVie-Allergan mega-merger
Daewoong Pharmaceutical's launch of Jeuveau, its botulinum toxin (BTX) ...
by Lee Han-soo  |  2019-08-07 16:22
라인
Lilly’s anticancer combo drug nears getting insurance benefit
Eli Lilly said its anticancer drug Verzenio showed an improvement in overal...
by Kim Yun-mi  |  2019-08-07 15:44
라인
Over 5,700 patients received Allergan’s breast implants linked to rare cancer
Health authorities around the world recently recalled Allergan’s breast imp...
by Song Soo-youn  |  2019-08-07 15:43
라인
[Reporter’s Notebook] SillaJen should be ashamed of itself
It was an obvious failure of a drug trial, but the drugmaker said it was no...
by Jeong Sae-im  |  2019-08-07 13:59
라인
Lilly reports improved survival for Verzenio in P3 trial
Eli Lilly Korea said that Verzenio (Ingredient: Abemaciclib) demonstrated a...
by Lee Han-soo  |  2019-08-07 12:06
라인
ISU Abxis to unveil p1 results for anticancer treatment in Europe
ISU Abxis will present its phase 1 clinical trial data for ISU104, an Erb-B...
by Lee Han-soo  |  2019-08-07 12:03
라인
Crystal Genomics signs accord with CRO firm
Crystal Genomics said that it has signed an agreement with PRA Health Scien...
by Lee Han-soo  |  2019-08-06 17:20
라인
Myongji Hospital opens sports medicine center
Myongji Hospital said that it has opened a new sports medicine center at th...
by Lee Han-soo  |  2019-08-06 16:54
라인
Japanese firms fear boycott may hurt prescription drug sales
Korean offshoots of Japanese pharmaceutical companies are worrying that the...
by Kim Yun-mi  |  2019-08-06 15:44
라인
Sillajen cites salvation therapy as reason for trial suspension advice
Sillajen said that it believes that the Independent Data Monitoring Committ...
by Lee Han-soo  |  2019-08-06 15:43
여백
여백
여백
Back to Top